Prescription Drug Utilization and Spending by Race, Ethnicity, Payer, Health Condition, and US State.

ABSTRACT:

Importance

Achieving equitable access to medicines requires understanding of how pharmaceutical use and spending vary by race and ethnicity across the US.

Objective

To quantify variation in prescription drug utilization and spending per capita and per prevalent case by race, ethnicity, health condition, payer, and US state.

Design, setting, and participants

In this cross-sectional study, the US Disease Expenditure project was extended to incorporate disaggregation by race and ethnicity for state-level retail prescription drug utilization and spending-in addition to 143 health conditions, 38 age and sex groups, and 4 payers (Medicare, Medicaid, private insurance, and out of pocket)-across the 2019 population in all 50 states and Washington, DC. Data were analyzed from

SUBMITTER: Sahu M 

PROVIDER: S-EPMC12334964 | biostudies-literature | 2025 Aug

REPOSITORIES: biostudies-literature